Arcutis Biotherapeutics, Inc. ARQT Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s other accrued liabilities?
- Arcutis Biotherapeutics, Inc. (ARQT) reported other accrued liabilities of $16.41M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s other accrued liabilities changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s other accrued liabilities increased by 71.6% year-over-year, from $9.57M to $16.41M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s other accrued liabilities?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s other accrued liabilities has grown at a 68.0% compound annual growth rate (CAGR), from $1.27M to $17.04M.